Compliance Rate

Compliance Rate 51.23%
Compliant submissions 187
Incompliant submissions 178
Total trials 365

My Organizations' Clinical Trials

Showing 1825 of 2400 entries
View as:

Rift Valley Fever in Kenya

Phase: N/A Priority: Normal
NCT ID: NCT00287014 Org: User:
Start: 03/31/06 End: 04/30/06 Due: 04/30/07

Molecular Epidemiology of Streptococcus Pyogenes Among Children in Bamako, Mali

Phase: N/A Priority: Normal
NCT ID: NCT00305123 Org: User:
Start: 04/30/06 End: 09/30/09 Due: 09/30/10

Safety, Tolerability, and Immunogenicity of the Vaccine Candidates ID93 + AP10-602 and ID93 + GLA-SE Administered Intramuscularly in Healthy Adult Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02508376 Org: User:
Start: 10/22/15 End: 08/31/17 Due: 08/31/18

Trial to Evaluate CIS43LS in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT04206332 Org: User:
Start: 01/07/20 End: 02/28/22 Due: 02/28/23

A Study of Nevirapine to Prevent HIV Transmission From Mothers to Their Infants

Phase: N/A Priority: Normal
NCT ID: NCT00001135 Org: User:
Start: - End: 05/31/01 Due: 05/31/02

Immune Responses in HIV-Positive Patients Receiving an Anti-HIV Drug Combination When Given the HIV Vaccines Remune and vCP1452

Phase: N/A Priority: Normal
NCT ID: NCT00006495 Org: User:
Start: - End: 09/30/04 Due: 09/30/05

Trizivir Vs. Kaletra and Combivir for the Prevention of Mother-to-Child Transmission of HIV

Phase: N/A Priority: Normal
NCT ID: NCT00270296 Org: User:
Start: 06/30/06 End: 09/30/10 Due: 09/30/11

Pleconaril Enteroviral Sepsis Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT00031512 Org: User:
Start: 06/27/01 End: 09/15/12 Due: 09/15/13

A Comparison of Adefovir and Tenofovir for the Treatment of Lamivudine-Resistant Hepatitis B Virus in People With HIV

Phase: N/A Priority: Normal
NCT ID: NCT00033163 Org: User:
Start: - End: 05/31/05 Due: 05/31/06

Changes in HIV Viral Load in Patients Undergoing Treatment for Filariasis

Phase: N/A Priority: Normal
NCT ID: NCT00344279 Org: User:
Start: 08/08/05 End: 01/31/12 Due: 01/31/13

HIV Assessment in Fuyang, Anhui Province, China

Phase: N/A Priority: Normal
NCT ID: NCT00094354 Org: User:
Start: 10/31/04 End: 04/30/06 Due: 04/30/07

Voluntary HIV Counseling, Testing, and Medication for Pregnant Women to Prevent Mother-to-Child HIV Transmission

Phase: N/A Priority: Normal
NCT ID: NCT00084045 Org: User:
Start: 11/30/04 End: 12/31/06 Due: 12/31/07

Interleukin-2 Therapy for HIV Infection - Supplemental Procedures

Phase: N/A Priority: Normal
NCT ID: NCT00001354 Org: User:
Start: 03/31/93 End: 03/31/02 Due: 03/31/03

Pramipexole Versus Escitalopram to Treat Major Depressive Disorder (MDD) and Comorbid MDD With Mild Neurocognitive Disorder (MND) in Persons With HIV

Phase: N/A Priority: Normal
NCT ID: NCT06705478 Org: User:
Start: 07/24/25 End: 12/02/26 Due: 12/02/27

A Clinical Trial to Evaluate the Safety and Immunogenicity of Glycan-trimmed HIV-1 Nanoparticle Vaccine (UVAX-1107), Followed by Homologous or Wild-type HIV-1 Nanoparticle Vaccine (UVAX-1197) Boost, Each Adjuvanted With 3M-052-AF + Alum in Adult Participants Without HIV

Phase: N/A Priority: Normal
NCT ID: NCT06905275 Org: User:
Start: 06/30/25 End: 07/20/27 Due: 07/20/28

Treatment Failure of Chlamydial Infection in Males and Females in Youth Correctional Facilities

Phase: N/A Priority: Normal
NCT ID: NCT00980148 Org: User:
Start: 12/31/09 End: 05/31/14 Due: 05/31/15

A Study of the Safety and Effectiveness of an HIV Vaccine for HIV-Positive Patients Receiving Anti-HIV Drugs for at Least 2 Years

Phase: N/A Priority: Normal
NCT ID: NCT00006509 Org: User:
Start: - End: 06/30/07 Due: 06/30/08

A Study of Pentamidine Plus Dapsone in the Prevention of Pneumocystis Carinii Pneumonia (PCP) in HIV-Infected Patients Who Cannot Take Trimethoprim or Sulfonamides

Phase: N/A Priority: Normal
NCT ID: NCT00001028 Org: User:
Start: - End: 06/30/94 Due: 06/30/95

Effects of Two Anti-HIV Drug Combinations on the Immune Systems of HIV-Infected Patients Who Have Never Received Anti-HIV Drugs

Phase: N/A Priority: Normal
NCT ID: NCT00004855 Org: User:
Start: - End: 04/30/05 Due: 04/30/06

VIBRANT: VIB4920 for Active Lupus Nephritis

Phase: N/A Priority: Normal
NCT ID: NCT05201469 Org: User:
Start: 05/16/22 End: 03/31/27 Due: 03/31/28

Safety and Effectiveness of Giving Isotretinoin to HIV-Infected Women to Treat Cervical Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00001073 Org: User:
Start: - End: 03/31/01 Due: 03/31/02

Safety and Immunogenicity of a Single Dose of the Recombinant Live-Attenuated Respiratory Syncytial Virus (RSV) Vaccines RSV ΔNS2/Δ1313/I1314L, RSV 6120/ΔNS2/1030s, RSV 276 or Placebo, Delivered as Nose Drops to RSV-Seronegative Children 6 to 24 Months of Age

Phase: N/A Priority: Normal
NCT ID: NCT03916185 Org: User:
Start: 06/20/19 End: 04/25/24 Due: 04/25/25

Carfilzomib and Belatacept for Desensitization

Phase: N/A Priority: Normal
NCT ID: NCT05017545 Org: User:
Start: 12/28/21 End: 02/28/28 Due: 02/28/29

Effectiveness of Interleukin-2 (IL-2) Plus Anti-HIV Therapy in HIV-Positive Patients

Phase: N/A Priority: Normal
NCT ID: NCT00001131 Org: User:
Start: 05/31/04 End: 06/30/07 Due: 06/30/08

Studies of Influenza Vaccine and Tetanus-Pneumococcal Vaccine in HIV-infected Patients Receiving Interleukin-2

Phase: N/A Priority: Normal
NCT ID: NCT00050726 Org: User:
Start: 05/31/01 End: 04/30/06 Due: 04/30/07